Effects of dietary energy repletion and IGF-1 infusion on the inhibition of mammary carcinogenesis by dietary energy restriction

Molecular Carcinogenesis

Volumn 42, Issue 3, 2005, Pages 170-176

  Zhu, Zongjian ^a   Jiang, Weiqin ^a   McGinley, John ^a   Wolfe, Pamela ^a   Thompson, Henry J ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

Dietary energy repletion; Dietary energy restriction; IGF 1 binding proteins; Mammary carcinogenesis

Indexed keywords

METHYLNITROSOUREA; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; BREAST CARCINOGENESIS; CALORIC INTAKE; CANCER INCIDENCE; CANCER INHIBITION; CARCINOGENICITY; CONTROLLED STUDY; FEMALE; INFUSION; NONHUMAN; PRIORITY JOURNAL; RAT; REFEEDING;

ANIMALS; BLOOD GLUCOSE; CALORIC RESTRICTION; CARCINOGENS; CELL TRANSFORMATION, NEOPLASTIC; CORTICOSTERONE; ENERGY INTAKE; FEMALE; GLUCOSE; GROWTH HORMONE; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MAMMARY NEOPLASMS, ANIMAL; METHYLNITROSOUREA; RATS; RATS, SPRAGUE-DAWLEY;

ANIMALIA;

EID: 13944255486     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/mc.20071     Document Type: Article

References (27)

1. Dirx MJ, Zeegers MP, Dagnelie PC, van den BT, van den Brandt PA. Energy restriction and the risk of spontaneous mammary tumors in mice: A meta-analysis. Int J Cancer 2003;106:766-770.
2. Birt DF, Copenhaver J, Barnett T, Pelling JC, Luthra R. Dietary fat and energy modulation of biochemical events in tumor promotion. Adv Exp Med Biol 1997;400B:925-929.
3. Kritchevsky D. Caloric restriction and experimental carcinogenesis. Hybrid Hybridomics 2002;21:147-151.
4. Hursting SD, Perkins SN, Phang JM, Barrett JC. Diet and cancer prevention studies in p53-deficient mice. J Nutr 2001;131:3092S-3094S.
5. Mai V, Colbert LH, Berrigan D, et al. Calorie restriction and diet composition modulate spontaneous intestinal tumorigenesis in Apc(Min) mice through different mechanisms. Cancer Res 2003;63:1752-1755.
6. Thompson HJ, Zhu Z, Jiang W. Dietary energy restriction in breast cancer prevention. J Mammary Gland Biol Neoplasia 2003;8:133-142.
7. Hursting SD, Lavigne JA, Berrigan D, Perkins SN, Barrett JC. Calorie restriction, aging, cancer prevention: Mechanisms of action and applicability to humans. Annu Rev Med 2003;54:131-152.
8. Jiang W, Zhu Z, Thompson HJ. Effect of energy restriction on cell cycle machinery in 1-methyl-1-nitrosourea-induced mammary carcinomas in rats. Cancer Res 2003;63:1228-1234.
9. Thompson HJ, Zhu Z, Jiang W. Identification of the apoptosis activation cascade induced in mammary carcinomas by energy restriction. Cancer Res 2004;64:1541-1545.
10. Zhu Z, Jiang W, Thompson HJ. An experimental paradigm for studying the cellular and molecular mechanisms of cancer inhibition by energy restriction. Mol Carcinog 2002;35:51-56.
11. Jiang W, Zhu Z, McGinley J, Thompson HJ. Adrenalectomy does not block the inhibition of mammary carcinogenesis by dietary energy restriction in rats. J Nutr 2004;134:1152-1156.
12. Giovannucci E. Insulin-like growth factor-I and binding protein-3 and risk of cancer. Horm Res 1999;51:34-41.
13. Pollak M. IGF-I physiology and breast cancer. Recent Results Cancer Res 1998;152:63-70.
14. Dunn SE, Kari FW, French J, et al. Dietary restriction reduces insulin-like growth factor I levels, which modulates apoptosis, cell proliferation, tumor progression in p53-deficient mice. Cancer Res 1997;57:4667-4672.
15. Thompson HJ. Methods for the induction of mammary carcinogenesis in the rat using either 7,12-dimethylben-z(a)antracene or 1-methyl-1-nitrosurea. In: Ip MM, Asch BB, editors. Methods in mammary gland biology and breast cancer research. New York: Kluwer Academic/Plenum Publishers; 2000. pp 19-29.
16. Zhu Z, Haegele AD, Thompson HJ. Effect of caloric restriction on pre-malignant and malignant stages of mammary carcinogenesis. Carcinogenesis 1997;18:1007-1012.
17. Thompson HJ, Singh M, McGinley J. Classification of premalignant and malignant lesions developing in the rat mammary gland after injection of sexually immature rats with 1-methyl-1-nitrosourea. J Mammary Gland Biol Neoplasia 2000;5:201-210.
18. Singh M, McGinley JN, Thompson HJ. A comparison of the histopathology of premalignant and malignant mammary gland lesions induced in sexually immature rats with those occurring in the human. Lab Invest 2000;80:221-231.
19. McCullagh P, Nelder JA. Generalized linear models. London: Chapman and Hall; 1989.
20. Snedecor GW, Cochran WG. Statistical methods. Ames, IA: Iowa State University Press; 1989.
21. Yang XF, Beamer WG, Huynh H, Pollak M. Reduced growth of human breast cancer xenografts in hosts homozygous for the lit mutation. Cancer Res 1996;56:1509-1511.
22. Hadsell DL, Bonnette SG. IGF and insulin action in the mammary gland: Lessons from transgenic and knockout models. J Mammary Gland Biol Neoplasia 2000;5:19-30.
23. Schwander JC, Hauri C, Zapf J, Froesch ER. Synthesis and secretion of insulin-like growth factor and its binding protein by the perfused rat liver: Dependence on growth hormone status. Endocrinology 1983;113:297-305.
24. Armstrong CS, Wuarin L, Ishii DN. Uptake of circulating insulin-like growth factor-I into the cerebrospinal fluid of normal and diabetic rats and normalization of IGF-II mRNA content in diabetic rat brain. J Neurosci Res 2000;59:649-660.
25. Ishii DN, Lupien SB. Insulin-like growth factor replacement therapy for diabetic neuropathy: Experimental basis. Exp Diabesity Res 2003;4:257-269.
26. Mejia-Naranjo W, Yakar S, Bernal R, Leroith D, Sanchez-Gomez M. Regulation of the splenic somatotropic axis by dietary protein and insulin-like growth factor-I in the rat. Growth Horm IGF Res 2003;13:254-263.
27. Upton Z, Webb H, Tomas FM, Ballard FJ, Francis GL. Characterization of serum-derived and recombinant rat IGF-I and their use for measuring true concentrations of IGF-I in rat plasma. J Endocrinol 1996;149:379-387.